{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:07:08Z","timestamp":1790554028435,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["2013\/R\/1"],"award-info":[{"award-number":["2013\/R\/1"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.neuropharm.2015.10.005","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T04:54:38Z","timestamp":1445403278000},"page":"82-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17"],"prefix":"10.1016","volume":"104","author":[{"given":"Marta","family":"Fumagalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3258-363X","authenticated-orcid":false,"given":"Davide","family":"Lecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Abbracchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.10.005_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/glia.20160","article-title":"Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development","volume":"50","author":"Agresti","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresrev.2004.12.005","article-title":"ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors","volume":"48","author":"Agresti","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12264-013-1322-2","article-title":"Signaling mechanisms regulating myelination in the central nervous system","volume":"29","author":"Ahrendsen","year":"2013","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cercor\/bhp193","article-title":"P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis","volume":"20","author":"Amadio","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.neuroscience.2006.05.058","article-title":"Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain","volume":"141","author":"Amadio","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2012.11.008","article-title":"Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies","volume":"325","author":"Asghari","year":"2013","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archneur.60.3.393","article-title":"White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study","volume":"60","author":"Bartzokis","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/glia.20885","article-title":"Role of the oligodendroglial cytoskeleton in differentiation and myelination","volume":"57","author":"Bauer","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","article-title":"Biology of oligodendrocyte and myelin in the mammalian central nervous system","volume":"81","author":"Baumann","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/glia.22432","article-title":"Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men","volume":"61","author":"Behrendt","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuroimage.2007.04.060","article-title":"Accelerated maturation of white matter in young children with autism: a high b value DWI study","volume":"37","author":"Ben Bashat","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1476-5381.2009.00633.x","article-title":"Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants","volume":"159","author":"Benned-Jensen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nbd.2009.11.009","article-title":"Promoting axonal rewiring to improve outcome after stroke","volume":"37","author":"Benowitz","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib15","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1523\/JNEUROSCI.5010-12.2013","article-title":"NG2 regulates directional migration of oligodendrocyte precursor cells via Rho GTPases and polarity complex proteins","volume":"33","author":"Biname","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1471-4159.1998.70041357.x","article-title":"A\u00a0novel orphan G protein-coupled receptor primarily expressed in the brain is localized on human chromosomal band 2q21","volume":"70","author":"Blasius","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib17","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/glia.21237","article-title":"The GPR17 receptor in NG2 expressing cells: focus on in\u00a0vivo cell maturation and participation in acute trauma and chronic damage","volume":"59","author":"Boda","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1464-410X.2010.09926.x","article-title":"Therapeutic potential of purinergic signaling for diseases of the urinary tract","volume":"107","author":"Burnstock","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2015.05.031","article-title":"An introduction to the roles of purinergic signaling in neurodegeneration, neuroprotection and neuroregeneration","volume":"104","author":"Burnstock","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib20","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1021\/jm901691y","article-title":"Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor","volume":"53","author":"Calleri","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib21","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/brain\/awp147","article-title":"The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury","volume":"132","author":"Ceruti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib22","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"12","author":"Chen","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib23","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11302-011-9250-y","article-title":"Emerging role of extracellular nucleotides and adenosine in multiple sclerosis","volume":"7","author":"Cieslak","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fncel.2015.00155","article-title":"Role of adenosine in oligodendrocyte precursor maturation","volume":"9","author":"Coppi","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2013.05.035","article-title":"Adenosine A(2)A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures","volume":"73","author":"Coppi","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/glia.22506","article-title":"UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors","volume":"61","author":"Coppi","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib28","doi-asserted-by":"crossref","first-page":"e63258","DOI":"10.1371\/journal.pone.0063258","article-title":"Cellular and molecular characterization of multipolar Map5-expressing cells: a subset of newly generated, stage-specific parenchymal cells in the mammalian central nervous system","volume":"8","author":"Crociara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib29","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.cellsig.2014.02.016","article-title":"Does GRK-beta arrestin machinery work as a \u201cswitch on\u201d for GPR17-mediated activation of intracellular signaling pathways?","volume":"26","author":"Daniele","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1044-7431(03)00210-0","article-title":"NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS","volume":"24","author":"Dawson","year":"2003","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11302-011-9283-2","article-title":"P2Y12 receptor expression is a critical determinant of functional responsiveness to ATX's MORFO domain","volume":"8","author":"Dennis","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.WCB.0000053472.41007.F9","article-title":"Oligodendrocytes and ischemic brain injury","volume":"23","author":"Dewar","year":"2003","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tins.2008.11.003","article-title":"Purinergic signaling in inflammation of the central nervous system","volume":"32","author":"Di Virgilio","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/glia.20958","article-title":"P2X7 receptors mediate ischemic damage to oligodendrocytes","volume":"58","author":"Domercq","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib35","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1158\/0008-5472.CAN-11-2632","article-title":"Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma","volume":"72","author":"Dougherty","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10822-011-9455-8","article-title":"In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases","volume":"25","author":"Eberini","year":"2011","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.1190927","article-title":"Regulation of oligodendrocyte differentiation and myelination","volume":"330","author":"Emery","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tins.2008.04.001","article-title":"White matter in learning, cognition and psychiatric disorders","volume":"31","author":"Fields","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn1928","article-title":"Purinergic signaling in neuron-glia interactions","volume":"7","author":"Fields","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0166-2236(00)01674-X","article-title":"ATP: an extracellular signaling molecule between neurons and glia","volume":"23","author":"Fields","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11302-013-9366-3","article-title":"Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury","volume":"9","author":"Franke","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib42","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib43","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1074\/jbc.M112.404996","article-title":"The regulated expression, intracellular trafficking and membrane recycling of the P2Y-like receptor GPR17 in Oli-neu oligodendroglial cells","volume":"288","author":"Fratangeli","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2013an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib45","doi-asserted-by":"crossref","first-page":"e1001604","DOI":"10.1371\/journal.pbio.1001604","article-title":"Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication","volume":"11","author":"Fruhbeis","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fncel.2013.00182","article-title":"Extracellular vesicles as mediators of neuron-glia communication","volume":"7","author":"Fruhbeis","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/glia.22896","article-title":"The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization","author":"Fumagalli","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib48","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"Fumagalli","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib49","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature11007","article-title":"Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity","volume":"485","author":"Funfschilling","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib50","article-title":"The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination","author":"Gonsalvez","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000079199","article-title":"Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging","volume":"18","author":"Gootjes","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.55782\/ane-2011-1823","article-title":"Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits","volume":"71","author":"Grygorowicz","year":"2011","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib53","doi-asserted-by":"crossref","first-page":"ra93","DOI":"10.1126\/scisignal.2004350","article-title":"Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist","volume":"6","author":"Hennen","year":"2013","journal-title":"Sci. Signal"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib54","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/glia.22737","article-title":"Adapting brain metabolism to myelination and long-range signal transduction","volume":"62","author":"Hirrlinger","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1159\/000335793","article-title":"Inhibition of leukotriene receptors boosts neural progenitor proliferation","volume":"28","author":"Huber","year":"2011","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib56","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00401-009-0635-8","article-title":"Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies","volume":"119","author":"Ihara","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib57","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1074\/jbc.C113.453704","article-title":"Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand","volume":"288","author":"Kanaoka","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2015.10.005_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/brain\/120.2.289","article-title":"The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up","volume":"120","author":"Kujala","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib60","doi-asserted-by":"crossref","first-page":"15243","DOI":"10.1523\/JNEUROSCI.1161-12.2012","article-title":"A\u00a0longitudinal study of the long-term consequences of drinking during pregnancy: heavy in utero alcohol exposure disrupts the normal processes of brain development","volume":"32","author":"Lebel","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib61","doi-asserted-by":"crossref","first-page":"e3579","DOI":"10.1371\/journal.pone.0003579","article-title":"The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair","volume":"3","author":"Lecca","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","article-title":"Oligodendroglia metabolically support axons and contribute to neurodegeneration","volume":"487","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib63","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/glia.22469","article-title":"A\u00a0functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination","volume":"61","author":"Li","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib64","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/nn.3263","article-title":"Impaired adult myelination in the prefrontal cortex of socially isolated mice","volume":"15","author":"Liu","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib65","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1073\/pnas.0905364106","article-title":"GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4","volume":"106","author":"Maekawa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib66","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1220845","article-title":"A\u00a0critical period for social experience-dependent oligodendrocyte maturation and myelination","volume":"337","author":"Makinodan","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.02.003","article-title":"The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis","volume":"127\u2013128","author":"Mallucci","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib68","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/glia.22476","article-title":"Neuronal activity promotes myelination via a cAMP pathway","volume":"61","author":"Malone","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcp.2005.10.003","article-title":"CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors","volume":"71","author":"Mamedova","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib70","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2012.09.033","article-title":"Periventricular leukomalacia long-term prognosis may be improved by treatment with UDP-glucose, GDNF, and memantine in neonatal rats","volume":"1486","author":"Mao","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12035-008-8028-x","article-title":"P2X7 receptors in oligodendrocytes: a novel target for neuroprotection","volume":"38","author":"Matute","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib72","doi-asserted-by":"crossref","first-page":"9525","DOI":"10.1523\/JNEUROSCI.0579-07.2007","article-title":"P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis","volume":"27","author":"Matute","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib73","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/brain\/awp076","article-title":"Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia","volume":"132","author":"Melani","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib74","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.4049\/jimmunol.1200545","article-title":"A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis","volume":"188","author":"Mills","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuroscience.2013.11.029","article-title":"Mechanisms regulating the development of oligodendrocytes and central nervous system myelin","volume":"276","author":"Mitew","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib76","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-010-0657-2","article-title":"Focal demyelination in Alzheimer's disease and transgenic mouse models","volume":"119","author":"Mitew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1523\/JNEUROSCI.0849-14.2015","article-title":"Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration","volume":"35","author":"Moyon","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib78","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1523\/JNEUROSCI.0805-13.2013","article-title":"Ascl1\/Mash1 promotes brain oligodendrogenesis during myelination and remyelination","volume":"33","author":"Nakatani","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib79","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","article-title":"Myelination and support of axonal integrity by glia","volume":"468","author":"Nave","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib80","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","article-title":"Myelination of the nervous system: mechanisms and functions","volume":"30","author":"Nave","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2051-5960-1-7","article-title":"NG2 cells, a new trail for Alzheimer's disease mechanisms?","volume":"1","author":"Nielsen","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrn2495","article-title":"Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity","volume":"10","author":"Nishiyama","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2012.04.079","article-title":"Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy","volume":"527","author":"O'Connor","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib84","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/glia.10281","article-title":"Oligodendrocytes express functional A1 adenosine receptors that stimulate cellular migration","volume":"44","author":"Othman","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6807-10-8","article-title":"Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach","volume":"10","author":"Parravicini","year":"2010","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2105-9-263","article-title":"GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors","volume":"9","author":"Parravicini","year":"2008","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib87","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib88","doi-asserted-by":"crossref","first-page":"C1028","DOI":"10.1152\/ajpcell.00658.2008","article-title":"Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells","volume":"297","author":"Pugliese","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib89","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/jcbfm.2013.85","article-title":"Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study","volume":"33","author":"Rissanen","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib90","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.1021\/bi026173d","article-title":"Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease","volume":"41","author":"Roher","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1474-4422(06)70410-0","article-title":"Secondary progressive multiple sclerosis: current knowledge and future challenges","volume":"5","author":"Rovaris","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib92","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/jm00088a014","article-title":"3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site","volume":"35","author":"Salituro","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib93","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.cellsig.2014.08.003","article-title":"Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in\u00a0vitro validation","volume":"26","author":"Sensi","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib94","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperlagh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib95","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1126\/science.287.5461.2267","article-title":"Response of Schwann cells to action potentials in development","volume":"287","author":"Stevens","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib96","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0896-6273(02)01067-X","article-title":"Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials","volume":"36","author":"Stevens","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib97","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1471-4159.1994.62031039.x","article-title":"Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II)","volume":"62","author":"Svennerholm","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib98","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12035-009-8063-2","article-title":"Purinoceptors on neuroglia","volume":"39","author":"Verkhratsky","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib99","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.4049\/jimmunol.1100333","article-title":"Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis","volume":"187","author":"Wang","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/glia.20758","article-title":"Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia","volume":"57","author":"Wang","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib101","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hbm.21042","article-title":"Abnormal white matter integrity in young children with autism","volume":"32","author":"Weinstein","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(01)00438-6","article-title":"Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions","volume":"121","author":"Whitney","year":"2001","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib103","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1523\/JNEUROSCI.23-12-04967.2003","article-title":"Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor","volume":"23","author":"Wilkins","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib104","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-5793(02)03540-8","article-title":"Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains","volume":"531","author":"Yoshioka","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib105","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuron.2013.01.006","article-title":"Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling","volume":"77","author":"Young","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib106","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.stem.2010.04.002","article-title":"CNS-resident glial progenitor\/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination","volume":"6","author":"Zawadzka","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fncel.2013.00201","article-title":"Oligodendrogenesis after cerebral ischemia","volume":"7","author":"Zhang","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib108","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/jcbfm.2010.134","article-title":"Ascl1 lineage cells contribute to ischemia-induced neurogenesis and oligodendrogenesis","volume":"31","author":"Zhang","year":"2011","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2015.10.005_bib109","doi-asserted-by":"crossref","first-page":"e48141","DOI":"10.1371\/journal.pone.0048141","article-title":"Sildenafil enhances neurogenesis and oligodendrogenesis in ischemic brain of middle-aged mouse","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2011.11.066","article-title":"The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats","volume":"202","author":"Zhao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.005_bib111","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T22:21:36Z","timestamp":1718144496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815301283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":111,"alternative-id":["S0028390815301283"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}